.5mg semaglutide in units how many is 1mg dosing chart units: complete conversion guide for every concentration Semaglutide 5mg/ml dosage chart: complete – Semaglutide Dosage Chart Units |

10.1523/JNEUROSCI.1955-10.2010 176

Appetite rebound can happen, and your plan may need nutrition changes, behavior support, medication reassessment, or more frequent follow-up

Study Design: Participants who achieved average 20.9% weight loss on tirzepatide over 36 weeks were randomized to either: Continue tirzepatide Switch to placebo Results at 88 Weeks (52 weeks after randomization): Continued Tirzepatide: Additional 5.5% weight loss Total weight loss: 25.3% from baseline 89.5% maintained at least 80% of initial weight loss Switched to Placebo: 14% weight regain Total weight loss: 9.9% from baseline Only 16.6% maintained at least 80% of initial weight loss Key Takeaway: Continued treatment is essential for maintaining weight loss

This can help prevent overeating and the urge to snack between meals

Conflict of Interest:Hyun-Jin Kim has been the editor of the CardioMetabolic Syndrome Journal since 2021 and was not involved in the review process of this article